LBA58Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. (23rd October 2018) - Popat, S; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; et al.